FAS and neoplasm: To determine the delivery efficiency of hFAS cDNA to the tumor site, we treated the xenograft-bearing mice with DOTAP-Chol-hFAS nanoparticles, collected tumor tissues one day later, isolated genomic DNA, and performed PCR using a pair of PCR primers that are specific for the codon-optimized human FAS cDNA sequence (Figure 7A).